Search Presentations content e.g. by keyword, title, location or presenter
Alice Street, 6.04.18
Presented at: Speculative Futures: A symposium and workshop exploring creative practices in health, technology and medicine in the global South, Slought Institute, Philadelphia
Speculative investments in a new generation of point-of-care diagnostic devices designed for resource-limited settings by philanthropists, development agencies and angel investors have focused on their capacity to revolutionise health service delivery in lower and middle income countries. Yet while the number of academic groups, organisations and companies devoted to researching and developing such devices in North America and Europe have multiplied over the past decade, the number of success stories are few and far between. This paper takes the failure of diagnostic speculation as a prompt to reimagine what a diagnostic revolution in global health might look like. It explores the alternative versions of diagnostic innovation that are emerging in the margins of global health, in spaces of citizen science, informal innovation, or academic deviance, and in both the North and South, to examine the alternative versions of medicine, science and development that such initiatives might offer for a post-Establishment future
Ann Kelly, Alice Street, Imogen Bevan, 1.02.18
Presented at: Liminal Spaces Workshop: Regulating for Uncertainty, Wellcome Collection, London
This paper explored how the tensions between the humanitarian imperatives of disease control and regulatory apprehensions of risk played out in the accelerated development, testing and licensure of Ebola diagnostics. Through the notion of the ‘evidentiary threshold’, she traced the normative and technical contours of the emerging paradigm of emergency research and development. Important questions were raised around the commitment to data sharing, lack of cross-validation and downstream challenges of gaining access to, and testing of, samples. These issues are compounded by regulatory ambiguity, lack of harmonisation, differences between minimum thresholds for approval versus deployment, and call for convergence between national regulatory structures. There can often be a disjunct between approval mechanisms that support and promote product development in the emergency context and the cross-over into the non-emergency context whereby access or further use is denied, blocked or subjected to entirely different, stand alone, regulatory paradigms.
Ann Kelly, 25.01.18
Presented at: Kings engaged in Africa 2018: security and development, Kings College London
Nanda Kishore Kannuri, 17.01.18
Presented at: Investigating diagnostics in global health: DiaDev Launch Event, University of Edinburgh
This presentation explored the questions around trust that emerge when malaria diagnostic tests transgress public/private and informal/formal boundaries in public health. What is the difference between trusting an individual, a system, or a device? Do diagnostic devices reduce uncertainty? And how does the diagnosis of malaria feed into the normalization of a disease?
Older Page 2 of 2